The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

Antipsychotic drug doses and neuroleptic/dopamine receptors

Philip Seeman, T. Lee, M. Chau-Wong et al. · Nature · 1976 · 1.6K citations

Medicine, Pharmacology, Psychiatry +13

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Alain Schotte, Paul Janssen, W Gommeren et al. · Psychopharmacology · 1996 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Binding of antipsychotic drugs to human brain receptors

Elliott Richelson, Terry Souder · Life Sciences · 2000 · 598 citations · Full text

Medicine, Pharmacology, Psychiatry +13

Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors

Mark J. Millan · Journal of Pharmacology and Experimental Therapeutics · 2000 · 287 citations

Medicine, Pharmacology, Psychiatry +17

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

Tetsuro Kikuchi, Katsura Tottori, Yasufumi Uwahodo et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 275 citations · Full text

Medicine, Neuroscience, Pharmacology +17